NANJING VAZYME BIOTECH CO.,LTD

Highlights Nanjing Vazyme Biotech Co.,Ltd

Equities

688105

CNE100004ZK3

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 03/06/2024 BST			5-day change	1st Jan Change
22.37 ^CNY	+1.08%		-2.74%	-30.14%

04-26	Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-15	Nanjing Vazyme Biotech Unit Gets Nod to Register Six Medical Devices; Shares Slump 14%	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
Nanjing Vazyme Biotech Unit Gets Nod to Register Six Medical Devices; Shares Slump 14%	04-15	MT
China stocks rise after new guidelines; HK shares drop	04-15	RE
Nanjing Vazyme Biotech Swings to Loss in 2023	02-29	MT
Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	02-28	CI
Nanjing Vazyme Biotech Co.,Ltd announces an Equity Buyback for CNY 160 million worth of its shares.	02-05	CI
Nanjing Vazyme Biotech Co., Ltd. authorizes a Buyback Plan.	02-04	CI
Tranche Update on Nanjing Vazyme Biotech Co.,Ltd's Equity Buyback Plan announced on August 22, 2023.	11-23	CI
Nanjing Vazyme Biotech Co.,Ltd's Equity Buyback announced on August 22, 2023, has closed with 618,077 shares, representing 0.15% for CNY 20.01 million.	11-23	CI
Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23	CI
Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23	CI
Nanjing Vazyme Biotech Plans Up to 30 Million Yuan Share Buyback	22/08/23	MT
Nanjing Vazyme Biotech Co.,Ltd announces an Equity Buyback for CNY 30 million worth of its shares.	21/08/23	CI
Nanjing Vazyme Biotech Co., Ltd. authorizes a Buyback Plan.	20/08/23	CI
Vazyme Biotech Registers New Pneumonia Pathogen Detection Kit	23/05/23	MT
Nanjing Vazyme Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23	CI
Nanjing Vazyme Biotech Unit Gets Registration Certificate for Pneumonia-Detecting Kit	19/04/23	MT
Nanjing Vazyme Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW